Market
Lanes are never summed. Equity is Form D filings and matched press rounds; awards and exits will have their own sources.
Health & bio: subsectors
6 subsectors, sized by amount sold · 90 days to 2026-10-04 · as of 2026-10-0416 rounds not yet in a sector
16 rounds not yet in a sector
- ▲ Rising
- Steady
- Leaning (80%)
- ▼ Falling
- Quiet
Coloured by subsector state, 28 days to 2026-10-03 vs prior 28; shaded when the change is clear at 90% confidence, palest when only at 80%.
Equity · amount sold
Capital by week
Dollars sold per filing week, round count under each bar · 4 weeks to 2026-10-04 · as of 2026-10-04Stage mix
Inferred stage · 90 days to 2026-10-04 · as of 2026-10-04- Pre-seed123 roundsPre-seed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $157MAmount sold in original Pre-seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Seed383 roundsSeed rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.2BAmount sold in original Seed filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series A287 roundsSeries A rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.7BAmount sold in original Series A filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series B88 roundsSeries B rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $3.5BAmount sold in original Series B filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Series C+84 roundsSeries C+ rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $28.8BAmount sold in original Series C+ filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
- Stage not inferred7 roundsStage not inferred rounds filed in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed → · $1.0BAmount sold in original Stage not inferred filings in the 90 days to 2026-10-04 · as of 2026-10-04How this is computed →
Bar length is each stage’s share of the window’s rounds. Dollars of original filings only: an amendment’s restated amount counts in the map, not here. Stage is inferred from the amount sold, never stated on Form D; a stage named in a press release wins.
Where it landed
Which states the money was raised from, by the company's HQ · 90 days to 2026-10-04 · as of 2026-10-04- $0+
- $353M+
- $1.4B+
- $3.2B+
- $5.7B+
Mega-rounds shown separately (see the band above)
Rounds
Newest first · every row traces to a Form D on EDGAR or a matched press release · as of 2026-10-04| Company | Sector | Stage | Sold of offered | Filed | HQ | Exemption | Open roles | Hiring | Flags | |
|---|---|---|---|---|---|---|---|---|---|---|
| Altay TherapeuticsQuiet$15.7M of $45.1M · Series A · Health & bio · 506(b) · San Carlos, CA · 2026-10-02New | Altay TherapeuticsNew | Health & bio | Series A | $15.7M of $45.1MAmount sold of the amount offered on the filing of 2026-10-02 · as of 2026-10-04How this is computed → | 2026-10-02 | San Carlos, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| VETmAb BiosciencesQuiet$11.4M of $11.9M · Series A · Health & bio · 506(b) · San Diego, CA · 2026-09-29New | VETmAb BiosciencesNew | Health & bio | Series A | $11.4M of $11.9MAmount sold of the amount offered on the filing of 2026-09-29 · as of 2026-10-04How this is computed → | 2026-09-29 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| Sialia Therapeutics, Inc.Quiet$1.5M of $1.5M · Seed · Health & bio · 506(b) · Irvine, CA · 2026-09-29New | Sialia Therapeutics, Inc.New | Health & bio | Seed | $1.5M of $1.5MAmount sold of the amount offered on the filing of 2026-09-29 · as of 2026-10-04How this is computed → | 2026-09-29 | Irvine, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | New |
| Navigator MedicinesQuiet$10.0M of $40.0M · Series A · Health & bio · 506(b) · San Mateo, CA · 2026-09-25 | Navigator Medicines | Health & bio | Series A | $10.0M of $40.0MAmount sold of the amount offered on the filing of 2026-09-25 · as of 2026-10-04How this is computed → | 2026-09-25 | San Mateo, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Caspian TherapeuticsQuiet$50.0M of $50.0M · Series B · Health & bio · 506(b) · San Diego, CA · 2026-09-23 | Caspian Therapeutics | Health & bio | Series B | $50.0M of $50.0MAmount sold of the amount offered on the filing of 2026-09-23 · as of 2026-10-04How this is computed → | 2026-09-23 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Aqur BiosciencesQuiet$1.5M of $1.5M · Seed · Health & bio · 506(b) · Westlake Village, CA · 2026-09-18 | Aqur Biosciences | Health & bio | Seed | $1.5M of $1.5MAmount sold of the amount offered on the filing of 2026-09-18 · as of 2026-10-04How this is computed → | 2026-09-18 | Westlake Village, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Moonwalk BiosciencesHiring actively$60.0M of $70.2M · Series B · Health & bio · 506(b) · South San Francisco, CA · 2026-09-14 | Moonwalk Biosciences | Health & bio | Series B | $60.0M of $70.2MAmount sold of the amount offered on the filing of 2026-09-14 · as of 2026-10-04How this is computed → | 2026-09-14 | South San Francisco, CA | 506(b) | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Tempo TherapeuticsHiring actively$14.0M of $14.5M · Series A · Health & bio · 506(b) · San Diego, CA · 2026-09-11 | Tempo Therapeutics | Health & bio | Series A | $14.0M of $14.5MAmount sold of the amount offered on the filing of 2026-09-11 · as of 2026-10-04How this is computed → | 2026-09-11 | San Diego, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| Iambic TherapeuticsHiring actively$66.0M of $66.5M · Series C+ · Health & bio · 506(b) · San Diego, CA · 2026-09-09AI-native | Iambic TherapeuticsAI-native | Health & bio | Series C+ | $66.0M of $66.5MAmount sold of the amount offered on the filing of 2026-09-09 · as of 2026-10-04How this is computed → | 2026-09-09 | San Diego, CA | 506(b) | 32The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Dravite Therapeutics, Inc.Quiet$53.0M of $53.0M · Series B · Health & bio · 506(b) · San Francisco, CA · 2026-09-03 | Dravite Therapeutics, Inc. | Health & bio | Series B | $53.0M of $53.0MAmount sold of the amount offered on the filing of 2026-09-03 · as of 2026-10-04How this is computed → | 2026-09-03 | San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Epicrispr BiotechnologiesQuiet$177M of $213M · Series C+ · Health & bio · 506(b) · South San Francisco, CA · 2026-08-26 | Epicrispr Biotechnologies | Health & bio | Series C+ | $177M of $213MAmount sold of the amount offered on the filing of 2026-08-26 · as of 2026-10-04How this is computed → | 2026-08-26 | South San Francisco, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AmplificaQuiet$25.0M of $25.0M · Series B · Health & bio · 506(b) · San Diego, CA · 2026-08-20 | Amplifica | Health & bio | Series B | $25.0M of $25.0MAmount sold of the amount offered on the filing of 2026-08-20 · as of 2026-10-04How this is computed → | 2026-08-20 | San Diego, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| ApollomicsQuiet$10.0M of $10.0M · Series A · Health & bio · 506(b) · Foster City, CA · 2026-08-19 | Apollomics | Health & bio | Series A | $10.0M of $10.0MAmount sold of the amount offered on the filing of 2026-08-19 · as of 2026-10-04How this is computed → | 2026-08-19 | Foster City, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Prana TherapiesQuiet$40.2M of $40.2M · Series B · Health & bio · 506(b) · Encinitas, CA · 2026-08-10 | Prana Therapies | Health & bio | Series B | $40.2M of $40.2MAmount sold of the amount offered on the filing of 2026-08-10 · as of 2026-10-04How this is computed → | 2026-08-10 | Encinitas, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Claris BioQuiet$55.7M of $121M · Series B · Health & bio · 506(b) · Half Moon Bay, CA · 2026-08-07AmendedUndersubscribed | Claris BioAmendedUndersubscribed | Health & bio | Series B | $55.7M of $121MAmount sold of the amount offered as of the filing of 2026-08-12 · as of 2026-10-04How this is computed → | 2026-08-07 | Half Moon Bay, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | AmendedUndersubscribed |
| Integrated BiosciencesHiring actively$68.4M of $100M · Series C+ · Health & bio · 506(b) · Redwood City, CA · 2026-08-05AI-native | Integrated BiosciencesAI-native | Health & bio | Series C+ | $68.4M of $100MAmount sold of the amount offered on the filing of 2026-08-05 · as of 2026-10-04How this is computed → | 2026-08-05 | Redwood City, CA | 506(b) | 5The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | AI-native |
| Mangrove Therapeutics Inc.Quiet$2.5M of $5.0M · Seed · Health & bio · 506(b) · Sacramento, CA · 2026-07-31 | Mangrove Therapeutics Inc. | Health & bio | Seed | $2.5M of $5.0MAmount sold of the amount offered on the filing of 2026-07-31 · as of 2026-10-04How this is computed → | 2026-07-31 | Sacramento, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| Sinopia BiosciencesHiring actively$2.8M of $4.3M · Seed · Health & bio · 506(b) · San Diego, CA · 2026-07-16 | Sinopia Biosciences | Health & bio | Seed | $2.8M of $4.3MAmount sold of the amount offered on the filing of 2026-07-16 · as of 2026-10-04How this is computed → | 2026-07-16 | San Diego, CA | 506(b) | 1The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| ImmunoVecHiring actively$12.7M of $15.0M · Series A · Health & bio · 506(b) · Los Angeles, CA · 2026-07-14 | ImmunoVec | Health & bio | Series A | $12.7M of $15.0MAmount sold of the amount offered on the filing of 2026-07-14 · as of 2026-10-04How this is computed → | 2026-07-14 | Los Angeles, CA | 506(b) | 3The company's open roles on its careers page · as of 2026-10-04How this is computed → | Hiring actively | |
| CeleCor TherapeuticsQuiet$11.9M of $15.0M · Series A · Health & bio · 506(b) · Del Mar, CA · 2026-07-09 | CeleCor Therapeutics | Health & bio | Series A | $11.9M of $15.0MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Del Mar, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet | |
| AmlogenyxQuiet$10.0M of $20.0M · Series A · Health & bio · 506(b) · Novato, CA · 2026-07-09 | Amlogenyx | Health & bio | Series A | $10.0M of $20.0MAmount sold of the amount offered on the filing of 2026-07-09 · as of 2026-10-04How this is computed → | 2026-07-09 | Novato, CA | 506(b) | 0The company's open roles on its careers page · as of 2026-10-04How this is computed → | Quiet |